Airway Therapeutics’ IND application for AT-100 gets FDA acceptance to treat Covid-19
The US Food and Drug Administration (FDA) has approved Investigational New Drug (IND) application submitted by Airway Therapeutics to develop AT-100 (rhSP-D) for treating patients with Covid-19.